Ivan Mesquita - Sanofi
Por um escritor misterioso
Descrição
IT SAP multiproduct Manager experienced delivering major projects in complex… | Obtén más información sobre la experiencia laboral, la educación, los contactos y otra información sobre Ivan Mesquita visitando su perfil en LinkedIn
Diabetes & Metabolism Journal
Ex Vivo Phenotypic Screening of Two Small Repurposing Drug
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA
PDF) Glanzmann's Thrombasthenia: How Listening to the Patient Is
Final Programme - iuphar
Cannes Lions Daily News 2013 - Thursday by Boutique Editions
The list of delegates to the 2020 World Economic Forum in Davos
Browse by Presenter
Ex Vivo Phenotypic Screening of Two Small Repurposing Drug
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With
Ivan Mesquita - Sanofi
Frontiers Mitochondrial epigenetics in aging and cardiovascular
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With
Relatório de Atividades 2017/18 by Instituto Reciclar - Issuu
Editors Scientific Reports
de
por adulto (o preço varia de acordo com o tamanho do grupo)
